Logo-jrhs
J Res Health Sci. 2023;23(1): e00572. doi: 10.34172/jrhs.2023.107
PMID: 37571943        PMCID: PMC10422145

Original Article

Survival Analysis of Patients with Colorectal Cancer Undergoing Combined Treatment: A Retrospective Cohort Study

Daem Roshani, Ghobad Moradi, Mohammad Aziz Rasouli *

Cited by CrossRef: 1

1- Myers M, Kosmacek E, Liew C, Chatterjee A, Wojtkiewicz M, Roy P, Hyde R, Dhawan P, Spasojevic I, Wang S, Hewitt K, Furdui C, Gundry R, Riethoven J, Lin C, Oberley-Deegan R. BMX-001 acts as a selective chemoradioprotector in rectal cancer. Redox Biochemistry and Chemistry. 2026;16:100074 [Crossref]
2- Liu M, Sansiriphun N, Udomkhwamsuk W, Lockwood C, Bhatarasakoon P. Caregiving experience of family caregivers for people with colorectal cancer: a qualitative systematic review protocol. 2025;23(7):1479 [Crossref]
3- Matovu N, Mugisha N, Jatho A, McShane C. Colorectal cancer research priorities in Uganda: perspectives from local key experts and stakeholders. Future Oncology. 2024;20(39):3169 [Crossref]
4- Fwelo P, Adekunle T, Adekunle T, Garza E, Huang E, Lawrence W, Ewing A. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment‐Related Factors. Cancer Medicine. 2025;14(5) [Crossref]
5- Rezazadeh M, Agah S, Kamyabi A, Ghamkhari Pisheh R, Eshraghi A, Tabaeian S, Akbari A. Impact of hypertension and angiotensin receptor blockers on colorectal cancer: A retrospective study. 2025;104(43):e45372 [Crossref]